J&J vaccine highly effective against severe COVID-19 – eNCA

In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe disease was 85.9% in the United States and 81.7% in South Africa.

LONDON – The single-shot Johnson & Johnson vaccine is highly effective in preventing severe COVID-19, including newer variants, according to documents released by the US Food and Drug Administrat…

See this full article at eNCA

Other news: